Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Jane Phillips

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
JAMA Dermatology|February 15, 2023
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysisErika Yue Lee, Christopher Knox, Elizabeth Jane Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2022
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year laterAna M Copaescu, Jaime S Rosa Duque, Elizabeth Jane Phillips
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Investigative Dermatology|December 22, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and HypersensitivityTafadzwa Chimbetete, Chloe Buck, Phuti Choshi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis SettingsRose Selim, Bukiwe Thwala, Mireille Porter, et al.
Nature Communications|August 10, 2019
Identification of drug-specific public TCR driving severe cutaneous adverse reactionsRen-You Pan, Mu-Tzu Chu, Chuang-Wei Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
JAMA Dermatology|February 15, 2023
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysisErika Yue Lee, Christopher Knox, Elizabeth Jane Phillips
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 7, 2022
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year laterAna M Copaescu, Jaime S Rosa Duque, Elizabeth Jane Phillips
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Investigative Dermatology|December 22, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and HypersensitivityTafadzwa Chimbetete, Chloe Buck, Phuti Choshi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 8, 2025
Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis SettingsRose Selim, Bukiwe Thwala, Mireille Porter, et al.
Nature Communications|August 10, 2019
Identification of drug-specific public TCR driving severe cutaneous adverse reactionsRen-You Pan, Mu-Tzu Chu, Chuang-Wei Wang, et al.
Pageof 1